Swiss Pharma Giant Roche To Invest $50Bn In US Within Five Years

(MENAFN- Swissinfo) Swiss pharmaceutical company Roche plans to invest up to $50 billion (CHF40.5 billion) in the United States over the next five years. Fellow Basel-based pharma company Novartis had already announced investments totalling billions almost a fortnight ago. This content was published on April 22, 2025 - 08:38 3 minutes Keystone-SDA

• Deutsch de Roche will innert 5 Jahren 50 Milliarden Dollar in USA investieren Original Read more: Roche will innert 5 Jahren 50 Milliarden Dollar in USA investiere

+Get the most important news from Switzerland in your inbox

According to a press release issued by Roche on Tuesday, the money is to be invested in both existing sites and new production facilities. The expansion would create up to 12,000 new jobs – around 1,000 at the pharmaceutical company alone and a further 11,000 to support the new US production capacities.

The funds will be channelled into US production and sales capacities for both the pharmaceuticals and diagnostics divisions. A state-of-the-art production facility for gene therapy is planned in Pennsylvania.

+ Novartis announces billion-dollar investment in US

Roche is also planning a new 900,000 square metre manufacturing centre to support its growing portfolio of next-generation weight loss medicines. The location of this centre is yet to be announced.

In addition, Roche will invest in a new research and development centre in Massachusetts to conduct cutting-edge research in artificial intelligence and serve as a hub for new research and development activities in cardiovascular, renal and metabolic areas.

More More Roche's big bet on big diseases

This content was published on Oct 20, 2024 Swiss pharma giant Roche is the latest company to refocus its R&D investment on diseases like obesity that weigh heavily on healthcare budgets.

Read more: Roche's big bet on big disease

MENAFN22042025000210011054ID1109456528